Trademarkia Logo

Canada

C$
Trademark Search in Canada
ROIVANT FOUNDATION

View On IC.GC.CA

ROIVANT FOUNDATION
ADVERTISED

on 23 Apr 2025

Last Applicant/ Owned by

Roivant Sciences GmbH

Viaduktstrasse 8CH-4051 Basel

CH

Serial Number

2089117 filed on 8th Jan 2021

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

ROIVANT FOUNDATION

Trademark usage description

pharmaceutical preparations for human use for use in dermatology, namely, dermatitis, skin pigmentation diseases, and skin injuries, for the treatment Read More

Classification Information

Class [005]
Pharmaceutical preparations for human use for use in dermatology, namely, dermatitis, skin pigmentation diseases, and skin injuries, for the treatment of central nervous system, neurological diseases and disorders, namely, myasthenia gravis, Alzheimer's, Huntington's Disease, cerebral palsy brain injury, spinal cord injury, seizure disorders, dementia, metabolic diseases and disorders, namely hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, hematologic, infectious diseases, namely, respiratory infections, eye infections, blood infections, skin infections, bladder infections, kidney infections, ear infections, sinus infections, dental infections, gastrointestinal infections, brain infections, spinal infections, viral respiratory infections, viral eye infections, viral blood infections, viral skin infections, viral bladder infections, viral kidney infections, viral ear infections, viral sinus infections, viral dental infections, viral gastrointestinal infections, viral brain infections, viral spinal infections and central nervous system infections, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions; biological preparations for medical or therapeutic use for use in dermatology, namely, dermatitis, skin pigmentation diseases, and skin injuries, for the treatment of central nervous system, neurological diseases and disorders, namely, myasthenia gravis, Alzheimer's, Huntington's Disease, cerebral palsy brain injury, spinal cord injury, seizure disorders, dementia, metabolic diseases and disorders, namely hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, hematologic, infectious diseases, namely, respiratory infections, eye infections, blood infections, skin infections, bladder infections, kidney infections, ear infections, sinus infections, dental infections, gastrointestinal infections, brain infections, spinal infections, viral respiratory infections, viral eye infections, viral blood infections, viral skin infections, viral bladder infections, viral kidney infections, viral ear infections, viral sinus infections, viral dental infections, viral gastrointestinal infections, viral brain infections, viral spinal infections and central nervous system infections, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions;

Classification kind code

11

Class [036]
Charitable fundraising services.

Classification kind code

11

Class [042]
Scientific and technological services as well as related research and design services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological-therapeutic research services; research in the fields of pharmaceutical and biological-therapeutic preparations, clinical trials and research post-authorization for the marketing of medicinal products and post-commercial launch of medicinal products; pharmaceutical research and development; provision of information in the field of scientific research in the fields of pharmaceuticals, biomedicine, clinical trials and research post-authorization for the marketing of medicinal products and post-commercial launch of medicinal products;

Classification kind code

11

Class [044]
Provision of health and medical information in the fields of medicine, general health and well-being, pharmaceutical and biomedical research and development, and of clinical trial and post-market trial data; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological preparations for the prevention and treatment of diseases, disorders and pathologies.

Classification kind code

11

Mark Details

Serial Number

2089117

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 16th Nov 2022		Agent Changed
Submitted for opposition 22
on 13th Jul 2022		Search Recorded
Submitted for opposition 20
on 13th Jul 2022		Examiner's First Report
Submitted for opposition 223
on 13th Jul 2022		Total Provisional Refusal
Submitted for opposition 256
on 4th Jan 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 4th Mar 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 3rd Mar 2021		Created
Submitted for opposition 31
on 3rd Mar 2021		Formalized
Submitted for opposition 30
on 8th Jan 2021		Filed
Submitted for opposition 228
on 8th Jan 2021		International Registration